-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HBV-IN-14
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2712529-19-4.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 2712529-19-4 |
| Description | HBV-IN-14 is a potent inhibitor of covalently closed circular DNA (cccDNA). cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-14 is a pyridinopyrimidinones compound. HBV-IN-14 has the potential for the research of HBV infection. |
Product Information
| Synonyms | HBV-IN-14|HY-144045|CS-0374983 |
| Molecular Weight | 428.87 |
| Molecular Formula | C22H21ClN2O5 |
| Canonical SMILES | CC1(CC(C1)OCCOC2=CC=C(C=C2)C3=CC(=O)N4C=CC=C(C4=N3)Cl)C(=O)O |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 833 |
| Exact Mass | 428.1138995 |
| Target | HBV; DNA/RNA Synthesis |
| XLogP3-AA | 2.9 |
